Weekly shot may replace daily growth hormone for turner syndrome kids
NCT ID NCT05690386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new long-acting growth hormone (lonapegsomatropin) given once a week, compared to the standard daily growth hormone shot, in 48 prepubertal children with Turner syndrome who have not had growth hormone before. The goal is to see if the weekly shot is safe and helps children grow as well as the daily shot. Participants will be randomly assigned to one of three doses of the weekly drug or the daily drug, and their growth will be tracked for up to 2 years, with an optional extension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TURNER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascendis Pharma Investigational Site
Palo Alto, California, 94304, United States
-
Ascendis Pharma Investigational Site
San Diego, California, 92123, United States
-
Ascendis Pharma Investigational Site
Aurora, Colorado, 80045, United States
-
Ascendis Pharma Investigational Site
Orlando, Florida, 32827, United States
-
Ascendis Pharma Investigational Site
St. Petersburg, Florida, 33701-4804, United States
-
Ascendis Pharma Investigational Site
Atlanta, Georgia, 30322, United States
-
Ascendis Pharma Investigational Site
Idaho Falls, Idaho, 83404, United States
-
Ascendis Pharma Investigational Site
Chicago, Illinois, 60611, United States
-
Ascendis Pharma Investigational Site
Boston, Massachusetts, 02114, United States
-
Ascendis Pharma Investigational Site
Saint Paul, Minnesota, 55102, United States
-
Ascendis Pharma Investigational Site
Las Vegas, Nevada, 89113, United States
-
Ascendis Pharma Investigational Site
Lake Success, New York, 11042, United States
-
Ascendis Pharma Investigational Site
Chapel Hill, North Carolina, 27599, United States
-
Ascendis Pharma Investigational Site
Cincinnati, Ohio, 45229, United States
-
Ascendis Pharma Investigational Site
Oklahoma City, Oklahoma, 73104, United States
-
Ascendis Pharma Investigational Site
Portland, Oregon, 97239, United States
-
Ascendis Pharma Investigational Site
El Paso, Texas, 79902, United States
-
Ascendis Pharma Investigational Site
Fort Worth, Texas, 76104, United States
-
Ascendis Pharma Investigational Site
Seattle, Washington, 98105, United States